Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

Venom Extracts

Venom Extracts, a subsidiary of Hollister Biosciences (HOLL.C), hit their second and final revenue milestone on December 9th, 2020, by pulling in CAD$40 million in revenue, starting from January…
Hollister Biosciences (HOLL.C) is normally a cannabis company. They have products in 220 dispensaries throughout California, and now they have caught wind that mushrooms might be the next big…
Last week Hollister Biosciences (HOLL.C) signed a letter of intent to acquire Arizona-based award-winning medical cannabis distillate and related product extraction brand, Venom Extracts, in an all stock deal…